Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Dumoutier

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
European Cytokine Network|April 17, 2002
Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functionsLaure Dumoutier, Jean-Christophe Renauld
Journal of Cellular and Molecular Medicine|March 3, 2022
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?Léna Puigdevall, Camille Michiels, Clara Stewardson, et al.
The Journal of Biological Chemistry|July 28, 2009
New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domainLaure Dumoutier, Carole de Meester, Jan Tavernier, et al.
Oncogene|June 26, 2002
Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2Aarne Fleischer, Verónica Ayllón, Laure Dumoutier, et al.
The Biochemical Journal|January 11, 2003
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3Laure Dumoutier, Diane Lejeune, Simon Hor, et al.
Journal of Immunological Methods|February 22, 2011
Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane proteinMuriel M Lemaire, Aurélie Vanhaudenarde, Yannick Nizet, et al.
Oncogene|March 28, 2003
MAP kinase activation by interleukin-9 in lymphoid and mast cell linesJean-Baptiste Demoulin, Jamila Louahed, Laure Dumoutier, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 6, 2018
Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in BelgiumLaurence de Montjoye, Anne Herman, Laure Dumoutier, et al.
The Journal of Biological Chemistry|June 28, 2002
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10Diane Lejeune, Laure Dumoutier, Stefan Constantinescu, et al.
The Journal of Biological Chemistry|May 29, 2004
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalingLaure Dumoutier, Amel Tounsi, Thomas Michiels, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
European Cytokine Network|April 17, 2002
Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functionsLaure Dumoutier, Jean-Christophe Renauld
Journal of Cellular and Molecular Medicine|March 3, 2022
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?Léna Puigdevall, Camille Michiels, Clara Stewardson, et al.
The Journal of Biological Chemistry|July 28, 2009
New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domainLaure Dumoutier, Carole de Meester, Jan Tavernier, et al.
Oncogene|June 26, 2002
Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2Aarne Fleischer, Verónica Ayllón, Laure Dumoutier, et al.
The Biochemical Journal|January 11, 2003
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3Laure Dumoutier, Diane Lejeune, Simon Hor, et al.
Journal of Immunological Methods|February 22, 2011
Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane proteinMuriel M Lemaire, Aurélie Vanhaudenarde, Yannick Nizet, et al.
Oncogene|March 28, 2003
MAP kinase activation by interleukin-9 in lymphoid and mast cell linesJean-Baptiste Demoulin, Jamila Louahed, Laure Dumoutier, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 6, 2018
Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in BelgiumLaurence de Montjoye, Anne Herman, Laure Dumoutier, et al.
The Journal of Biological Chemistry|June 28, 2002
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10Diane Lejeune, Laure Dumoutier, Stefan Constantinescu, et al.
The Journal of Biological Chemistry|May 29, 2004
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalingLaure Dumoutier, Amel Tounsi, Thomas Michiels, et al.
Pageof 8